Publication: 503

Publication: 503

Outcome of advanced NSCLC patients with EGFR exon 19 and 21 mutations treated with erlotinib (E) alone or in combination with carboplatin/paclitaxel (CP) in CALGB 30406

URL

Google Scholar

Citation:: J Thorac Oncol vol 6 (suppl 2) abstr O39.01

Meeting Instance:: IASLC (WCLC) 2011
Year:: 2011
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 712

Program:: OGC
Primary Committee:: Respiratory
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: P. A. Janne X. Wang M. A. Socinski J. Crawford L. Gu M. Capelletti M. J. Edelman M. A. Villalona-Calero R. A. Kratzke E. E. Vokes V. A. Miller

Networks:

Study: CALGB-30406
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: